습진 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 8.1%로 성장할 전망이며, 243억 5,000만 달러로 성장이 예측됩니다. 예측 기간 동안 성장은 아토피 피부염 치료 수요 증가, 업무활동 증가, 습진 인지도 향상, 생물학적 제제 사용 확대, 원격의료 플랫폼 채용 확대 등에 기인할 것으로 보입니다. 예측 기간 주요 동향으로는 전략적 제휴, 새로운 치료법의 개발, 주사약의 대두, 맞춤형 의료의 진전 등을 들 수 있습니다.
자가면역 질환의 유병률 증가는 향후 수년간 습진 시장의 확대를 촉진할 것으로 예측됩니다. 자가면역질환은 신체의 면역계가 실수로 건강한 세포나 조직, 장기를 공격해 염증이나 손상을 일으키면서 발생합니다. 이러한 질환의 이환율의 증가는 유전적 감수성, 환경 요인, 감염증, 식생활의 변화, 스트레스나 오염 물질에 대한 폭로 등의 라이프 스타일의 영향과 관련되어 있습니다. 건선, 루푸스, 류마티스 관절염 등 자가면역질환은 면역반응의 이상과 관련이 있으며 습진이나 기타 염증성 피부질환의 가능성을 높이고 있습니다. 예를 들어 2024년 11월 독일을 거점으로 하는 조직인 Versorgungsatlas.de 은 2022년 7324만 1305명의 피보험자 중 630만 4340명이 최소 1개의 자가면역질환 진단을 받았다고 보고했습니다. 그 결과 자가면역질환 유병률 증가가 습진 시장 성장에 박차를 가하고 있습니다.
습진 시장의 주요 기업은 치료 효과를 향상시키고 전문적인 스킨 케어 솔루션에 대한 수요 증가에 대응하기 위해 첨단 습진 케어 크림과 같은 혁신적인 제품 개발에 주력하고 있습니다. 습진 케어 크림은 환부의 피부를 진정시키고 촉촉하게 해주며 보호하며 가려움증, 염증, 건조함을 줄여주도록 처방되어 있습니다. 예를 들어 2024년 9월 영국 퍼스널케어 브랜드인 Dove사는 Baby Dove Eczema Care Soothing Bath Treatment와 Baby Dove Eczema Care Cream을 포함한 영유아용 새로운 습진 케어 시리즈를 출시했습니다. 이 제품 라인은 습진을 가진 영유아를 위해 특별히 설계되었으며 민감한 피부에 대한 부드러움을 보장하기 위해 100% 피부 천연 영양소를 특징으로 합니다. 콜로이드 오트밀(1.0%)이 함유되어 피부 거칠어짐을 막아주고 수분을 유지하는 중요한 성분으로 알려져 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장-거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
- 세계의 습진 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
- 최종 이용 산업의 분석
- 세계의 습진 시장 : 성장률 분석
- 세계의 습진 시장 실적 : 규모 및 성장(2019-2024년)
- 세계의 습진 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
- 세계의 습진 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 습진 시장 : 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 아토피 피부염
- 접촉성 피부염
- 지루성 피부염
- 기타 유형
- 세계의 습진 시장 : 치료 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 국소 치료
- 경구약
- 생물학적 제형
- 광선요법
- 세계의 습진 시장 : 연령층별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 소아
- 성인
- 노인
- 세계의 습진 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 병원 또는 진료소
- 피부과 센터
- 홈케어
- 약국
- 세계의 습진 시장 : 아토피 피부염 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 국소 스테로이드
- 국소 칼시뉴린 억제제
- 보습제
- 생물학적 요법
- 세계의 습진 시장 : 접촉성 피부염 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 국소 스테로이드
- 항히스타민제
- 국소 면역억제제
- 습포
- 세계의 습진 시장 : 지루성 피부염 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 항진균 크림 또는 샴푸
- 국소 스테로이드
- 약용 샴푸
- 국소 칼시뉴린 억제제
- 세계의 습진 시장 : 기타 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 알레르기성 피부염
- 화폐상 피부염
- 신경성 피부염
- 땀포성 이한증 습진
제7장 지역별 및 국가별 분석
- 세계의 습진 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 습진 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
- 습진 시장 : 경쟁 구도
- 습진 시장 : 기업 프로파일
- Pfizer Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- AbbieVie Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Bayer AG 개요, 제품 및 서비스, 전략 및 재무 분석
- Sanofi SA 개요, 제품 및 서비스, 전략 및 재무 분석
- Bristol-Myers Squibb Company 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- AstraZeneca PLC
- Novartis AG
- GlaxoSmithKline plc
- Amgen
- Hoffmann-La Roche AG
- Eli Lilly and Co.
- Siemens Healthineers AG
- Viatris Inc.
- Teva Pharmaceutical Industries Ltd.
- Regeneron Pharmaceuticals Inc.
- Astellas Pharma Inc
- Bausch Health Companies Inc.
- Galderma
- Cadila Pharmaceuticals Ltd.
- LEO Pharma A/S
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
- 습진 시장(2029년) : 새로운 기회를 제공하는 국가
- 습진 시장(2029년) : 새로운 기회를 제공하는 부문
- 습진 시장(2029년) : 성장 전략
제36장 부록
AJY
Eczema is a chronic inflammatory skin condition marked by redness, itching, dryness, and irritation. It results from a combination of genetic and environmental factors, leading to a weakened skin barrier and an overactive immune response. While eczema can affect individuals of all ages, it is more common in children. The condition often occurs in flare-ups triggered by allergens, irritants, stress, or climate changes.
The primary types of eczema include atopic dermatitis, contact dermatitis, seborrheic dermatitis, and other variations. Atopic dermatitis, commonly referred to as eczema, is a chronic skin disorder characterized by itchy, red, and inflamed skin, often aggravated by allergens, irritants, or stress. Treatment options for eczema include topical treatments, oral medications, biologics, and phototherapy. The condition affects various age groups, including children, adults, and the elderly, and is managed across different healthcare settings such as hospitals, clinics, dermatology centers, home care, and pharmacies.
The eczema market research report is one of a series of new reports from The Business Research Company that provides eczema market statistics, including the eczema industry global market size, regional shares, competitors with the eczema market share, detailed eczema market segments, market trends, and opportunities, and any further data you may need to thrive in the eczema industry. This eczema market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The eczema market size has grown strongly in recent years. It will grow from $16.41 billion in 2024 to $17.81 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth during the historic period can be attributed to the increasing prevalence of autoimmune diseases, the rising cases of eczema, greater regulatory approvals, the growing incidence of air pollution, and the increasing burden of allergic reactions.
The eczema market size is expected to see strong growth in the next few years. It will grow to $24.35 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth during the forecast period can be attributed to the rising demand for atopic dermatitis treatment, increasing operational activities, greater awareness of eczema, the growing use of biologics, and the expanding adoption of telemedicine platforms. Key trends in the forecast period include strategic collaborations, the development of emerging therapies, the rise of injectable drugs, and the advancement of personalized medicine.
The rising prevalence of autoimmune disorders is expected to drive the expansion of the eczema market in the coming years. Autoimmune disorders occur when the body's immune system mistakenly attacks healthy cells, tissues, or organs, leading to inflammation and damage. The growing incidence of these conditions is linked to genetic susceptibility, environmental factors, infections, dietary changes, and lifestyle influences such as stress and exposure to pollutants. Autoimmune diseases such as psoriasis, lupus, and rheumatoid arthritis are associated with dysregulated immune responses, increasing the likelihood of eczema and other inflammatory skin conditions. For example, in November 2024, Versorgungsatlas.de, a Germany-based organization, reported that in 2022, out of 73,241,305 insured individuals, 6,304,340 were diagnosed with at least one autoimmune disease, resulting in a raw prevalence rate of 8.61%. Consequently, the increasing prevalence of autoimmune disorders is fueling the growth of the eczema market.
Leading companies in the eczema market are focusing on developing innovative products, such as advanced eczema care creams, to improve treatment effectiveness and meet the growing demand for specialized skincare solutions. Eczema care creams are formulated to soothe, hydrate, and protect affected skin, reducing itching, inflammation, and dryness. For instance, in September 2024, Dove, a UK-based personal care brand, launched a new Eczema Care range for babies, including the Baby Dove Eczema Care Soothing Bath Treatment and the Baby Dove Eczema Care Cream. This product line is designed specifically for infants with eczema, featuring 100% skin-natural nutrients to ensure gentleness on sensitive skin. Additionally, the formulations contain colloidal oatmeal (1.0%), a key ingredient known for soothing irritation and maintaining skin moisture.
In May 2024, Johnson & Johnson, a US-based pharmaceutical company, acquired Proteologix Inc. for approximately $850 million. This acquisition aims to strengthen Johnson & Johnson's position in treating atopic dermatitis (AD) and asthma by integrating innovative bispecific antibody therapies into its product portfolio. Proteologix Inc. is a US-based biotechnology company specializing in the development of bispecific antibodies for immune-mediated diseases.
Major players in the eczema market are Pfizer Inc., AbbieVie Inc., Bayer AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Amgen, Hoffmann-La Roche AG, Eli Lilly and Co., Siemens Healthineers AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc, Bausch Health Companies Inc., Galderma, Cadila Pharmaceuticals Ltd., LEO Pharma A/S, Almirall, Kyowa Kirin, Alliance Pharma Plc, Encore Dermatology Inc., Arcutis Inc.
North America was the largest region in the eczema market in 2024. The regions covered in eczema report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the eczema market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The eczema market consists of revenues earned by entities by providing services such as diagnosis and consultation services, prescription and medication services, phototherapy services, allergy testing and immunotherapy, and skin barrier repair therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The eczema market also includes sales of antihistamines, topical corticosteroids, calcineurin inhibitors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Eczema Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on eczema market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for eczema ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The eczema market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Atopic Dermatitis; Contact Dermatitis; Seborrheic Dermatitis; Other Types
- 2) By Treatment Type: Topical Treatments; Oral Medications; Biologics; Phototherapy
- 3) By Age Group: Children; Adults; Elderly
- 4) By End User: Hospitals Or Clinics; Dermatology Centers; Home Care; Pharmacies
- Subsegments:
- 1) By Atopic Dermatitis: Topical Steroids; Topical Calcineurin Inhibitors; Moisturizers; Biologic Therapies
- 2) By Contact Dermatitis: Topical Steroids; Antihistamines; Topical Immunosuppressants; Wet Compresses
- 3) By Seborrheic Dermatitis: Antifungal Creams or Shampoos; Topical Steroids; Medicated Shampoos; Topical Calcineurin Inhibitors
- 4) By Other Types: Allergic Dermatitis; Nummular Dermatitis; Neurodermatitis; Dyshidrotic Eczema
- Companies Mentioned: Pfizer Inc.; AbbieVie Inc.; Bayer AG; Sanofi S.A; Bristol-Myers Squibb Company
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Eczema Market Characteristics
3. Eczema Market Trends And Strategies
4. Eczema Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Eczema Growth Analysis And Strategic Analysis Framework
- 5.1. Global Eczema PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Eczema Market Growth Rate Analysis
- 5.4. Global Eczema Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Eczema Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Eczema Total Addressable Market (TAM)
6. Eczema Market Segmentation
- 6.1. Global Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Atopic Dermatitis
- Contact Dermatitis
- Seborrheic Dermatitis
- Other Types
- 6.2. Global Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Topical Treatments
- Oral Medications
- Biologics
- Phototherapy
- 6.3. Global Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Children
- Adults
- Elderly
- 6.4. Global Eczema Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals Or Clinics
- Dermatology Centers
- Home Care
- Pharmacies
- 6.5. Global Eczema Market, Sub-Segmentation Of Atopic Dermatitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Topical Steroids
- Topical Calcineurin Inhibitors
- Moisturizers
- Biologic Therapies
- 6.6. Global Eczema Market, Sub-Segmentation Of Contact Dermatitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Topical Steroids
- Antihistamines
- Topical Immunosuppressants
- Wet Compresses
- 6.7. Global Eczema Market, Sub-Segmentation Of Seborrheic Dermatitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Antifungal Creams or Shampoos
- Topical Steroids
- Medicated Shampoos
- Topical Calcineurin Inhibitors
- 6.8. Global Eczema Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Allergic Dermatitis
- Nummular Dermatitis
- Neurodermatitis
- Dyshidrotic Eczema
7. Eczema Market Regional And Country Analysis
- 7.1. Global Eczema Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Eczema Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Eczema Market
- 8.1. Asia-Pacific Eczema Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Eczema Market
- 9.1. China Eczema Market Overview
- 9.2. China Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Eczema Market
- 10.1. India Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Eczema Market
- 11.1. Japan Eczema Market Overview
- 11.2. Japan Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Eczema Market
- 12.1. Australia Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Eczema Market
- 13.1. Indonesia Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Eczema Market
- 14.1. South Korea Eczema Market Overview
- 14.2. South Korea Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Eczema Market
- 15.1. Western Europe Eczema Market Overview
- 15.2. Western Europe Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Eczema Market
- 16.1. UK Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Eczema Market
- 17.1. Germany Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Eczema Market
- 18.1. France Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Eczema Market
- 19.1. Italy Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Eczema Market
- 20.1. Spain Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Eczema Market
- 21.1. Eastern Europe Eczema Market Overview
- 21.2. Eastern Europe Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Eczema Market
- 22.1. Russia Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Eczema Market
- 23.1. North America Eczema Market Overview
- 23.2. North America Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Eczema Market
- 24.1. USA Eczema Market Overview
- 24.2. USA Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Eczema Market
- 25.1. Canada Eczema Market Overview
- 25.2. Canada Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Eczema Market
- 26.1. South America Eczema Market Overview
- 26.2. South America Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Eczema Market
- 27.1. Brazil Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Eczema Market
- 28.1. Middle East Eczema Market Overview
- 28.2. Middle East Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Eczema Market
- 29.1. Africa Eczema Market Overview
- 29.2. Africa Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Eczema Market Competitive Landscape And Company Profiles
- 30.1. Eczema Market Competitive Landscape
- 30.2. Eczema Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. AbbieVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi S.A Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
31. Eczema Market Other Major And Innovative Companies
- 31.1. AstraZeneca PLC
- 31.2. Novartis AG
- 31.3. GlaxoSmithKline plc
- 31.4. Amgen
- 31.5. Hoffmann-La Roche AG
- 31.6. Eli Lilly and Co.
- 31.7. Siemens Healthineers AG
- 31.8. Viatris Inc.
- 31.9. Teva Pharmaceutical Industries Ltd.
- 31.10. Regeneron Pharmaceuticals Inc.
- 31.11. Astellas Pharma Inc
- 31.12. Bausch Health Companies Inc.
- 31.13. Galderma
- 31.14. Cadila Pharmaceuticals Ltd.
- 31.15. LEO Pharma A/S
32. Global Eczema Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Eczema Market
34. Recent Developments In The Eczema Market
35. Eczema Market High Potential Countries, Segments and Strategies
- 35.1 Eczema Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Eczema Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Eczema Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
